BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27041820)

  • 1. Drug-Initiated Synthesis of Polymer Prodrugs: Combining Simplicity and Efficacy in Drug Delivery.
    Nicolas J
    Chem Mater; 2016 Mar; 28(6):1591-1606. PubMed ID: 27041820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supramolecular nanomedicines through rational design of self-assembling prodrugs.
    Wang H; Monroe M; Leslie F; Flexner C; Cui H
    Trends Pharmacol Sci; 2022 Jun; 43(6):510-521. PubMed ID: 35459589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-acting, function-responsive, and high drug payload nanospheres for combining simplicity and efficacy in both self-targeted multi-drug co-delivery and synergistic anticancer effect.
    Li Y; Lin J; Liu G; Ma J; Xie L; Guo F; Zhu X; Hou Z
    Int J Pharm; 2016 Oct; 512(1):194-203. PubMed ID: 27566011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid prodrug nanocarriers in cancer therapy.
    Mura S; Bui DT; Couvreur P; Nicolas J
    J Control Release; 2015 Jun; 208():25-41. PubMed ID: 25617724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Initiated Synthesis of Heterotelechelic Polymer Prodrug Nanoparticles for in Vivo Imaging and Cancer Cell Targeting.
    Vinciguerra D; Degrassi A; Mancini L; Mura S; Mougin J; Couvreur P; Nicolas J
    Biomacromolecules; 2019 Jul; 20(7):2464-2476. PubMed ID: 31150219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Strategies in Stimuli-Responsive Prodrug Nanosystems for Cancer Therapy.
    Ding C; Chen C; Zeng X; Chen H; Zhao Y
    ACS Nano; 2022 Sep; 16(9):13513-13553. PubMed ID: 36048467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines.
    Fattahi N; Shahbazi MA; Maleki A; Hamidi M; Ramazani A; Santos HA
    J Control Release; 2020 Oct; 326():556-598. PubMed ID: 32726650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
    Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
    Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-Sensitive Hyaluronic Acid Polymer Prodrug Nanoparticles for Enhancing Intracellular Drug Self-Delivery and Targeted Cancer Therapy.
    Lu B; Xiao F; Wang Z; Wang B; Pan Z; Zhao W; Zhu Z; Zhang J
    ACS Biomater Sci Eng; 2020 Jul; 6(7):4106-4115. PubMed ID: 33463311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in prodrug-based nanoparticle therapeutics.
    Chen KJ; Plaunt AJ; Leifer FG; Kang JY; Cipolla D
    Eur J Pharm Biopharm; 2021 Aug; 165():219-243. PubMed ID: 33979661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent trends in bioresponsive linker technologies of Prodrug-Based Self-Assembling nanomaterials.
    Nguyen A; Böttger R; Li SD
    Biomaterials; 2021 Aug; 275():120955. PubMed ID: 34130143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Block copolymer prodrugs: Synthesis, self-assembly, and applications for cancer therapy.
    Dutta D; Ke W; Xi L; Yin W; Zhou M; Ge Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1585. PubMed ID: 31452353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulus-responsive self-assembled prodrugs in cancer therapy.
    Dong X; Brahma RK; Fang C; Yao SQ
    Chem Sci; 2022 Apr; 13(15):4239-4269. PubMed ID: 35509461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A robust strategy for preparation of sequential stimuli-responsive block copolymer prodrugs via thiolactone chemistry to overcome multiple anticancer drug delivery barriers.
    Ke W; Yin W; Zha Z; Mukerabigwi JF; Chen W; Wang Y; He C; Ge Z
    Biomaterials; 2018 Feb; 154():261-274. PubMed ID: 29149720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of polymer conjugation and drug targeting for the delivery of proteins and bioactive molecules.
    Grigoletto A; Tedeschini T; Canato E; Pasut G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1689. PubMed ID: 33314717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 100th Anniversary of Macromolecular Science Viewpoint: Biological Stimuli-Sensitive Polymer Prodrugs and Nanoparticles for Tumor-Specific Drug Delivery.
    Sun H; Zhong Z
    ACS Macro Lett; 2020 Sep; 9(9):1292-1302. PubMed ID: 35638634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli-responsive prodrug-based cancer nanomedicine.
    Xie A; Hanif S; Ouyang J; Tang Z; Kong N; Kim NY; Qi B; Patel D; Shi B; Tao W
    EBioMedicine; 2020 Jun; 56():102821. PubMed ID: 32505922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles as delivery carriers for anticancer prodrugs.
    Fang JY; Al-Suwayeh SA
    Expert Opin Drug Deliv; 2012 Jun; 9(6):657-69. PubMed ID: 22507134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.